Bonus BioGroup Ltd. (BBIXF)
Bonus BioGroup Ltd.
20 Madain Industries Center
POB 15143
Haifa 3190501
Israel
972 7 3206 7100
https://bonus-bio.com
Sector(es): Healthcare
Industria: Biotechnology
Empleados a tiempo completo: 58
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Joseph Rauch M.B.A. | Executive Chairman of the Board | 1.5M | N/D | 1957 |
| Dr. Shai Meretzki Ph.D. | Founder, CEO, President & Director | 1.98M | N/D | 1969 |
| Mr. Yoni Livne CPA | Chief Financial Officer | 718k | N/D | 1975 |
| Dr. Dror Ben David Ph.D. | Chief Operations Officer. | 500k | N/D | N/D |
| Dr. Vered Kivity M.B.A., Ph.D. | Head of Regulatory Affairs & VP of Clinical Affairs | N/D | N/D | N/D |
Descripción
Bonus BioGroup Ltd., a clinical-stage biotechnology company, develops products based on tissue engineering and cell therapy. The company's products in development include BonoFill for bone tissue regeneration in maxillofacial and orthopedic indications and is in Phase II clinical trial; and MesenCure for the treatment of COVID patients suffering from pneumonia and ARDS and is in phase III trial. Its products in pipeline also comprise BonoFill for bone augmentation in osteoporosis patients; MesenCure for treating other inflammations and tissue damage; vascularized bone grafts; and soft tissue grafts. The company was formerly known as Oceana Advanced Industries Ltd. Bonus BioGroup Ltd. was incorporated in 1981 and is based in Haifa, Israel.
Gestión corporativa
La calificación ISS Governance QuickScore de Bonus BioGroup Ltd. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.
